Canada · Health Canada Drug Product Database
WIXELA INHUB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 98549
- DIN
- 02495597
- Form
- Powder
- Company as listed by source
- MYLAN PHARMACEUTICALS ULC
- Source status
- Marketed (2020-02-13)
- Source last updated
- 2025-03-22
Source-listed ingredients
- FLUTICASONE PROPIONATE — 100 MCG — per 1 ACT
- SALMETEROL (SALMETEROL XINAFOATE) — 50 MCG — per 1 ACT
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →